Crypto Breaking News

A key gauge of US consumer prices rose by more than expected last month, bolstering the case for Federal Reserve officials to raise interest rates next week. The consumer price index, excluding food and energy, climbed 0.3% in August from a month earlier, according to Bureau of Labor Statistics data out Friday. The median estimate in a Bloomberg survey called for a 0.2% increase. On an annual basis, it advanced 2.4%. Futures showed investors priced in a rate hike next week as a near certainty following the release, and put a high likelihood on a second increase before the end of the year. We got reaction from Sarah Hunt, Chief Market Strategist at Alpine Saxon Woods. She speaks with Bloomberg's Paul Sweeney and Lisa Mateo.

National Economic Council Director Kevin Hassett says inflation is "clearly decelerating" over the last three months as he discusses the US August CPI report. Hassett also talks about respecting Federal Reserve independence on interest-rate decisions and the potential path to President Donald Trump's suggestion of a $5,000 payment if Republicans keep control of the House and Senate in the midterm elections. Hassett also reflects on his personal experiences on September 11, 2001.

On this episode of Stock Movers: - Kroger (KR) is moving as it trimmed its annual sales guidance due to fierce competition for grocery spending. - Oracle (ORCL) shares are higher as the software company's results featured better-than-expected cloud revenue amid strong AI demand. - Restoration Hardware (RH) shares are on the move after the home furnishing retailer's quarterly earnings beat amid a weaker housing market and consumer spending environment.

Conservative Party of Canada Leader Pierre Poilievre discusses the state of trade and tariffs with the United States. He says Canada's oil and mineral resources can help alleviate US inflation pressures, but the Trump administration needs to back off its tariff policies against its northern neighbor. He speaks on "Bloomberg Surveillance."

Tiffany Wilding, economist at Pimco, says US CPI data for August "does result in a Federal Reserve that is hiking interest rates." She speaks on "Bloomberg Surveillance."

A key gauge of US consumer prices climbed by more than expected last month, bolstering the case for Federal Reserve officials to raise interest rates next week. Michael McKee breaks down the data on Bloomberg Television.

Jeff Currie, founder & CEO at Real Macro and co-founder & director at 1947 Oil and Gas, discusses the impact of China's return to the oil market, shortages in oil and crude products, and the possibility of $5 gasoline in the US ahead of the midterm elections.

Jeff Currie, founder & CEO at Real Macro and co-founder & director at 1947 Oil and Gas, explains why the need for refineries to balance production of gasoline and diesel products can push gas prices higher ahead of the US midterm elections.

"We have to appreciate that we could be in the midst of a now secular uptrend in bond yields," says Cameron Dawson, chief investment officer at NewEdge Wealth. She does see "tactical buying opportunities" in US Treasuries and says rising yields will continue to put downward pressure on equity valuations. Dawson speaks on "Bloomberg Surveillance."

Isabelle Mateos y Lago, chief economist at BNP Paribas, discusses the weight of Friday's US CPI report on the upcoming Federal Reserve interest-rate decision. She says her firm believes "monetary policy is not restrictive enough" and that the US economy "probably" needs three rate hikes, starting next week.

Bundesbank President Joachim Nagel, speaking Thursday at the European Central Bank's monetary policy press conference in Berlin, said he's worried about the rise of far-right parties such as Alternative for Germany. "Some of these [far-right] concepts are self-defeating in an economic sense," Nagel explains. "Is this helpful to attract foreign investors to come to this country? Definitely not."

SV Health Investors' Ruth McKernan says wearables and health data are helping move medicine from the general to the personal. She says AI is already speeding up parts of drug discovery and improving patient selection for clinical trials. But McKernan says some parts of development cannot be rushed, and the UK still needs more funding to help life-sciences companies scale. She spoke to Tom Mackenzie on the latest episode of Bloomberg Tech: Europe.